Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Net Cash Flow (2024 - 2025)

Beta Bionics' Net Cash Flow history spans 2 years, with the latest figure at -$6.9 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 153.35% year-over-year to -$6.9 million; the TTM value through Dec 2025 reached $1.1 million, down 70.41%, while the annual FY2025 figure was $1.1 million, 70.41% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$6.9 million at Beta Bionics, down from $3.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $13.0 million in Q4 2024 and bottomed at -$9.0 million in Q2 2024.